BCKDHB rs121908697: Understanding the Ashkenazi Jewish Carrier Variant
The rs121908697 variant is a specific genetic change in the BCKDHB gene that is recognized as a founder mutation within the Ashkenazi Jewish population. It is associated with carrier status for Maple Syrup Urine Disease (MSUD), a rare metabolic condition that affects how the body processes certain amino acids.
What each genotype means
Typical BCKDHB function
This genotype represents the common, non-variant sequence for this position in the BCKDHB gene. Individuals with this profile do not carry the specific missense variant associated with Maple Syrup Urine Disease (MSUD) type 1B in this context.
This is the most common genotype observed across all global populations.
Carrier of MSUD variant
This genotype indicates you are a carrier of the c.548A>G (p.Asn183Ser) variant in the BCKDHB gene. Carriers are typically asymptomatic, as this condition follows an autosomal recessive inheritance pattern, but you should discuss the implications for family planning with a genetic counselor.
This variant is a known founder mutation in the Ashkenazi Jewish population, with an estimated carrier frequency of approximately 1 in 97.
Increased risk for MSUD
This genotype indicates the presence of two copies of the variant, which is associated with classic Maple Syrup Urine Disease (MSUD) type 1B. This condition impairs the body's ability to break down certain amino acids, leading to toxic buildup; please consult with a metabolic specialist or physician for clinical evaluation and management.
This homozygous genotype is rare and is primarily identified in clinical settings among individuals with a confirmed diagnosis of MSUD.
What is the rs121908697 Variant?
The variant rs121908697, often referred to in clinical literature as c.548G>C or p.Arg183Pro, is a single nucleotide polymorphism located within the BCKDHB gene. This gene provides the instructions for creating a critical component of an enzyme complex responsible for breaking down branched-chain amino acids. When a change occurs at this specific position, it can alter the structure of the resulting protein. In the context of genetic testing, this variant is identified as a missense mutation, meaning the genetic code is altered in a way that substitutes one amino acid for another during protein synthesis. Because this variant is well-documented in specific ancestral groups, it is frequently included in carrier screening panels designed to assess the risk of passing on certain recessive genetic conditions to future generations.
The Role of the BCKDHB Gene
The BCKDHB gene is essential for the proper function of the branched-chain alpha-ketoacid dehydrogenase complex. This complex is vital for the metabolism of three specific amino acids: leucine, isoleucine, and valine. These amino acids are building blocks of protein found in many common foods, such as meat, eggs, and dairy. When the BCKDHB gene is functioning correctly, the body efficiently breaks down these amino acids for energy. However, if mutations occur in this gene, the enzyme complex may become inactive or deficient. This leads to an accumulation of these amino acids and their toxic byproducts in the body. This buildup is the hallmark of Maple Syrup Urine Disease, a condition named for the distinct, sweet odor it can cause in the urine of affected infants.
Research and Clinical Significance
Research has established that rs121908697 is a founder mutation, meaning it is more common in the Ashkenazi Jewish population due to historical population patterns. Clinical evidence classifies this variant as pathogenic, meaning it is known to cause disease when inherited in a specific pattern. MSUD is an autosomal recessive disorder, which means an individual must inherit two copies of a pathogenic variant—one from each parent—to manifest the symptoms of the disease. Individuals who carry only one copy of this variant are typically asymptomatic carriers. The evidence for this variant's role in MSUD is strong within the context of carrier screening, as it accounts for a significant portion of the disease-causing mutations identified in individuals of Ashkenazi Jewish descent.
Population Frequency and Distribution
The frequency of the rs121908697 variant varies significantly across different global populations. In the Ashkenazi Jewish population, the allele frequency is approximately 0.005, making it a notable marker for genetic counseling in this community. While MSUD is rare worldwide, affecting roughly 1 in 185,000 newborns, the prevalence of specific variants like this one can be much higher in certain ethnic groups. It is important to note that while this variant is a primary focus for Ashkenazi Jewish carrier screening, other populations may have different, unique mutations in the BCKDHB, BCKDHA, or DBT genes that contribute to MSUD. Genetic testing results should always be interpreted in the context of an individual's specific ancestry and family history.
Understanding Your Results
If you have received information regarding your status for rs121908697, it is important to understand what this means in a clinical context. Being identified as a carrier does not mean you have the disease, nor does it mean you will develop symptoms. Because MSUD is recessive, carriers generally remain healthy. However, if both parents are carriers of a pathogenic variant in the same gene, there is a one-in-four chance with each pregnancy that the child will inherit two copies and be affected by the condition. This information is intended for educational purposes and should not be used for self-diagnosis. If you have concerns about your carrier status or family planning, you should consult with a certified genetic counselor or a medical professional who can provide personalized guidance based on your specific genetic report.
How common is this variant?
The rs121908697 variant has an allele frequency of approximately 0.005 in the Ashkenazi Jewish population, where it is recognized as a founder mutation.
Frequently asked questions
What is a carrier of MSUD?
A carrier of MSUD has one copy of a mutated gene associated with the condition but does not show symptoms. They are healthy but can pass the variant to their children.
Does having this variant mean I have MSUD?
No, having one copy of the variant makes you a carrier, not a patient. MSUD is a recessive condition that typically requires two copies of a pathogenic variant to manifest.
Should I be tested for MSUD?
Carrier testing is often recommended for individuals planning a family, especially those from populations where specific variants are more common. Discuss this with a genetic counselor to see if it is appropriate for you.
Can I change my genotype?
No, your genotype is determined at conception and cannot be changed. Genetic information is a permanent part of your biological makeup.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908697?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BCKDHB
Pathogenic missense mutation (p.Arg183Pro) in BCKDHB causing maple syrup urine disease type 1B.
Pathogenic BCKDHB missense variant (p.Arg183Pro) causative of Maple Syrup Urine Disease (MSUD) type 1B, common in expanded carrier panels.
Pathogenic variant (c.827T>G; p.Arg276Gly) associated with maple syrup urine disease type 1B.
This variant in the BCKDHB gene is linked to Maple Syrup Urine Disease and is documented in clinical variant databases.